Search for: "AMGEN INC."
Results 361 - 380
of 704
Sorted by Relevance
|
Sort by Date
6 Nov 2022, 2:18 pm
In Amgen Inc. v. [read post]
26 Aug 2021, 1:05 pm
Cir. 2001) (citation omitted); Amgen Inc. v. [read post]
14 Jun 2012, 2:58 am
Amgen, Inc. [read post]
14 Jun 2012, 2:58 am
Amgen, Inc. [read post]
9 Jul 2012, 5:04 pm
Amgen Inc., 660 F.3d 1170 (9th Cir., 11/8/11), the Ninth Circuit Court of Appeals discussed the fraud-on-the-market presumption of reliance in securities fraud class actions. [read post]
20 Mar 2007, 11:21 am
"Among the companies being sued under for such claims: AstraZeneca, Pfizer Inc., Johnson & Johnson, Amgen Inc., Eli Lilly & Co., GlaxoSmithKline PLC, Bayer Corp. and Hoffman-LaRoche Inc. [read post]
11 Oct 2011, 1:49 pm
The petitions of the day are: Amgen Inc. v. [read post]
27 Oct 2009, 7:04 am
Big health-care spenders in the third quarter of 2009 included Pfizer Inc.with $5.42 million; the American Hospital Association with $3.8 million, the American Medical Association with $3.95 million, Amgen Inc. ($3 million); Bayer Corp. ($2.45 million) and America’s Health Insurance Plans ($2.4 million). [read post]
1 Oct 2012, 10:29 am
The Supreme Court in Amgen, Inc. v. [read post]
17 Jul 2012, 10:05 am
The lawsuit was initially filed in 2002 by Ivey Woodard, a former employee of Amgen, the drug maker that sells Epogen. [read post]
20 Dec 2008, 5:32 am
With both houses of Congress expected to renew their efforts to pass patent reform and follow-on biologics bills in 2009, we provide the following update on third quarter biotech/pharma lobbying activities: • Amgen Inc. spent $2.4 million on third... [read post]
5 Aug 2012, 9:04 pm
” Citing Amgen Inc. v. [read post]
2 Feb 2014, 9:40 am
” Amgen, Inc. v. [read post]
19 Mar 2014, 9:00 am
There are two other pending biologic cases in Canada: (1) Teva’s filgrastim Subsequent Biologic Entry (“SEB”) case against Amgen was discontinued on consent in August 2013 (the parties had earlier settled in the US). [read post]
29 Apr 2014, 8:34 am
Relying heavily on Amgen Inc. v. [read post]
31 Jul 2013, 5:25 pm
Medline Industries, Inc.). [read post]
26 Dec 2011, 7:57 pm
" Health Policy previously highlighted two petitions for certiorari filed this fall that sought to bring this matter to the Supreme Court: Amgen Inc. et al., v. [read post]
9 Feb 2009, 5:10 am
However, if such claims are based solely on allegations that the respective defendants violated the FDCA, then the claims are preempted.The case involves a group of seven health benefit plans accusing Amgen, Inc., DaVita, Inc. and Fresenius Medical Care Holdings, Inc. of unlawfully promoting the off-label use of two drugs, Epogen and Aranesp (collectively, “EPO”), between 2002 and 2007. [read post]
23 Apr 2024, 10:28 am
See, Amgen Inc. v. [read post]
8 Oct 2009, 12:37 pm
In Amgen Inc. v. [read post]
